The settlement of a patent dispute over the blockbuster cholesterol drug will delay the release of generic versions in the United States until 2011.

The settlement of a patent dispute over the blockbuster cholesterol drug will delay the release of generic versions in the United States until 2011.

The settlement of a patent dispute over the blockbuster cholesterol drug will delay the release of generic versions in the U.S. until 2011.